TRANSVAC looks to the future and is exploring the implementation of a road map towards a sustainable vaccine research infrastructure in Europe beyond TRANSVAC. To this end TRANSVAC organises a series of European vaccine development stakeholders working groups committed to formulate a European vaccine development road map with the main goals to: 

• Create an environment in which innovation, technology development and knowledge transfer can thrive, and
• Establishing infrastructures that will secure vaccine R&D and manufacturing in Europe.

The foundation for this Agenda for Action was laid during the TRANSVAC European Vaccine Development Stakeholders Meeting in Brussels in October 2010. In the frame of TRANSVAC, EVI brought together representatives of vaccine manufacturers, biotech companies, academic research, regulatory authorities, product development partnerships and funding agencies to:

• Identify the gaps and needs in vaccine research and development in Europe, and to
• Identify which activities or structures could improve the development of new vaccines and technologies in order to sustain and strengthen European leadership in the field of vaccines.

Download the full Report of the 2010 TRANSVAC European Vaccine Development Stakeholders Meeting.

The first workshop was held in Brussels on the 7th of October 2011. This first will focus on two main topics: I) how to sustain and increase support for translational vaccine research II) training in vaccinology in Europe

Download the full Report of the 2011 TRANSVAC Workshop on translational vaccine research and training in vaccinology. 

If you have specific questions on the TRANSVAC stakeholders working group workshops, please contact transvacinfo [at] euvaccine [dot] eu (Dr Mark Geels.)